Identifying Optimal Antibiotic Regimens to Treat Urinary Tract Infections During Pregnancy
确定治疗妊娠期尿路感染的最佳抗生素方案
基本信息
- 批准号:10838231
- 负责人:
- 金额:$ 5.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-01 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:Alaska NativeAmbulatory CareAmerican College of Obstetricians and GynecologistsAmerican IndiansAntibioticsAntimicrobial ResistanceAntimicrobial susceptibilityAwardBacteriuriaBiometryBlack raceCaringChildClinicalCommunicable DiseasesCongenital AbnormalityDataDevelopmentDiagnosisDisparityDisparity in diagnosisEffectivenessElectronic Health RecordEpidemiologyEthnic OriginEthnic PopulationExclusionFailureFirst Pregnancy TrimesterFoundationsGoalsGrantGuidelinesHealthHealth Disparities ResearchHealth Services AccessibilityHealthcare SystemsHispanicImprove AccessIncidenceInfantInfant HealthInfant MortalityInfectionIntegrated Health Care SystemsInterventionKnowledgeLow Birth Weight InfantMaster of ScienceMaternal HealthMentorsNative HawaiianNot Hispanic or LatinoOutcomePacific IslanderParentsPatientsPatternPersonsPharmacoepidemiologyPopulationPopulation HeterogeneityPregnancyPregnancy lossPregnant WomenPremature BirthPremature LaborPrevalencePyelonephritisRaceRecommendationRegimenResearchResearch PersonnelResearch SupportRiskSafetySepsisStudentsTalentsTreatment FailureUncertaintyUnderrepresented PopulationsUniversitiesUrinary tract infectionVariantWashingtonWomanWomen&aposs Healthadverse outcomecareercareer developmentcomparative effectivenesscomparative safetyearly pregnancyeffective therapyethnic differenceethnic disparityexperiencehealth disparityhealth equityimprovedineffective therapiesmultidisciplinaryperinatal complicationspregnancy related deathpregnantprogramsracial differenceracial disparityracial minority populationracial populationrandomized trialresearch and developmentroutine screeningscreening guidelinesskillsstandard of caresymposiumtreatment durationtreatment guidelinestreatment risktv watchingunderserved community
项目摘要
PROJECT SUMMARY
Urinary tract infections (UTIs) are common in pregnancy and can have serious consequences including
pregnancy loss and preterm birth. Minoritized racial and ethnic groups may have higher rates of UTI in
pregnancy, but prior studies had important limitations. While some evidence suggests there are racial and
ethnic disparities in diagnosis and treatment of other infections, little is known about potential disparities in UTI
treatment in pregnancy. This Diversity Supplement would support Ms. Sandra McAteer, a talented master's
student in Epidemiology at the University of Washington, to conduct relevant research and gain skills and
experience needed for a successful career as a program manager leading interventions to improve the health
of women and children. Ms. McAteer's primary mentor will be Dr. Sascha Dublin of Kaiser Permanente
Washington, Co-Investigator on the Parent R01 grant. Dr. Anjum Hajat of the University of Washington will be
co-mentor, bringing expertise in health disparities research. The Parent R01 aims to generate needed
evidence about the comparative safety and effectiveness of antibiotics in pregnancy by analyzing
administrative claims and electronic health records data. The Specific Aims of the Parent R01 are: 1) to
characterize real-world prescribing patterns, concordance with existing guidelines, and antimicrobial
susceptibility patterns relevant to the outpatient treatment of UTIs in pregnancy; 2) to compare the risk of
treatment failure with commonly-used antibiotic regimens; and 2) to evaluate the comparative safety of these
antibiotic regimens with respect to birth defects and perinatal complications. The Parent R01 does not include
a health equity focus, and specifically, it does not examine whether there are differences in UTI incidence or
treatment or in the prevalence of antimicrobial resistance by race or ethnicity. Specific Aims of the proposed
Diversity Supplement Research are to characterize differences in the incidence and treatment of UTI in
pregnancy by patient race and ethnicity, including differences in choice of antibiotic and concordance of
treatment with clinical guidelines. For an exploratory aim, Ms. McAteer will examine differences in antimicrobial
resistance by race and ethnicity. Ms. McAteer's Career Development and Research Plan will include
coursework, directed readings, participation in seminars and conferences, and conducting research supported
by a multidisciplinary group of mentors. These activities will help her build the scientific and professional skills
for a successful career as a program manager leading interventions to improve the health of women and
children from underrepresented groups. Impact: The proposed Diversity Supplement will augment the Parent
R01 by adding a health equity focus and increasing knowledge about differences in incidence and treatment of
UTIs by race and ethnicity. Results could be used to develop targeted interventions to improve care for UTIs in
pregnancy and ultimately to improve health outcomes for pregnant people and infants.
项目概要
尿路感染 (UTI) 在怀孕期间很常见,可能会造成严重后果,包括
妊娠丢失和早产。少数种族和族裔群体的尿路感染发病率可能更高
怀孕,但之前的研究有重要的局限性。虽然一些证据表明存在种族和
其他感染的诊断和治疗方面存在种族差异,但人们对尿路感染的潜在差异知之甚少
怀孕期间的治疗。该多样性补充品将支持桑德拉·麦卡蒂尔女士(Sandra McAteer),她是一位才华横溢的硕士
华盛顿大学流行病学专业的学生,进行相关研究并获得技能和
作为项目经理领导改善健康的干预措施,成功职业生涯所需的经验
妇女和儿童。 McAteer 女士的主要导师将是 Kaiser Permanente 的 Sascha Dublin 博士
华盛顿,Parent R01 资助项目的联合研究员。华盛顿大学的 Anjum Hajat 博士将
共同导师,带来健康差异研究方面的专业知识。 Parent R01 旨在生成所需的
通过分析获得有关妊娠期抗生素相对安全性和有效性的证据
行政索赔和电子健康记录数据。母版 R01 的具体目标是: 1)
描述现实世界的处方模式、与现有指南的一致性以及抗菌药物
与妊娠期尿路感染门诊治疗相关的易感性模式; 2)比较风险
常用抗生素治疗失败; 2)评估这些药物的相对安全性
针对出生缺陷和围产期并发症的抗生素治疗方案。父 R01 不包括
健康公平焦点,具体而言,它不检查尿路感染发病率或
治疗或按种族或族裔划分的抗菌药物耐药性流行情况。拟议的具体目标
多样性补充研究旨在描述不同地区尿路感染的发病率和治疗差异
不同种族和民族的妊娠情况,包括抗生素选择和药物一致性的差异
按照临床指南进行治疗。为了实现探索性目标,麦卡蒂尔女士将研究抗菌剂的差异
种族和民族的抵抗。麦卡蒂尔女士的职业发展和研究计划将包括
课程作业、定向阅读、参加研讨会和会议以及开展研究支持
由多学科导师组成的小组。这些活动将帮助她培养科学和专业技能
作为一名项目经理,领导改善妇女健康的干预措施,取得成功的职业生涯
来自代表性不足群体的儿童。影响:拟议的多样性补充将增强家长的能力
R01 通过增加对健康公平的关注并增加对疾病发病率和治疗差异的了解
按种族和民族划分的尿路感染。结果可用于制定有针对性的干预措施,以改善对尿路感染的护理
怀孕并最终改善孕妇和婴儿的健康结果。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Anne Mobley Butler其他文献
Anne Mobley Butler的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Anne Mobley Butler', 18)}}的其他基金
Comparative Risk of Oral Complications Associated with Medications for Opioid Use Disorder: A Mixed-Methods Approach
与阿片类药物使用障碍药物相关的口腔并发症的风险比较:混合方法
- 批准号:
10765049 - 财政年份:2023
- 资助金额:
$ 5.88万 - 项目类别:
Comparative Effectiveness and Safety of Adjuvanted and Other Influenza Vaccine Technologies Among Patients Receiving Dialysis
佐剂和其他流感疫苗技术在接受透析的患者中的有效性和安全性比较
- 批准号:
10726047 - 财政年份:2023
- 资助金额:
$ 5.88万 - 项目类别:
Identifying Optimal Antibiotic Regimens to Treat Urinary Tract Infections During Pregnancy
确定治疗妊娠期尿路感染的最佳抗生素方案
- 批准号:
10522361 - 财政年份:2022
- 资助金额:
$ 5.88万 - 项目类别:
Identifying Optimal Antibiotic Regimens to Treat Urinary Tract Infections During Pregnancy
确定治疗妊娠期尿路感染的最佳抗生素方案
- 批准号:
10672395 - 财政年份:2022
- 资助金额:
$ 5.88万 - 项目类别:
相似海外基金
Integrating mental health screening into endocrinology ambulatory care
将心理健康筛查纳入内分泌门诊护理
- 批准号:
23K16283 - 财政年份:2023
- 资助金额:
$ 5.88万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Recovery Bridge: A Peer Facilitated Intervention to help bridge the transition from psychiatric inpatient hospitalization to living in the community
康复桥梁:同伴协助干预,帮助弥合从精神病住院到社区生活的过渡
- 批准号:
10637987 - 财政年份:2023
- 资助金额:
$ 5.88万 - 项目类别:
Personalized Risk Prediction for Prevention and Early Detection of Postoperative Failure to Rescue
个性化风险预测,预防和早期发现术后抢救失败
- 批准号:
10753822 - 财政年份:2023
- 资助金额:
$ 5.88万 - 项目类别:
I-TRANSFER-HF: Improving TRansitions ANd OutcomeS for Heart FailurE Patients in Home Health CaRe: A Type 1 Hybrid Effectiveness Implementation Trial
I-TRANSFER-HF:改善家庭医疗保健中心力衰竭患者的过渡和结果:1 型混合有效性实施试验
- 批准号:
10714524 - 财政年份:2023
- 资助金额:
$ 5.88万 - 项目类别:
Opioid-Sparing Non-Surgical, Bioresorbable Nerve Stimulator for Pain Relief
节省阿片类药物的非手术生物可吸收神经刺激器,用于缓解疼痛
- 批准号:
10759642 - 财政年份:2023
- 资助金额:
$ 5.88万 - 项目类别: